Sandip Kapadia, CFO of Harmony Biosciences Holdings, Inc. ($HRMY), made seven open market sales of company shares over the last year, totaling about $2.8 million. His most recent sale occurred on January 26, 2026. These HRMY insider sales rank 2,833rd among 11,678 individual insiders by total value, below the average of $8.6 million per seller and slightly above the average of 6.4 transactions. Kapadia reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 3746 | $37.15 | 24,521.0000 | 58,544,570 | 13.25% | 0.01% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2239 | $36.82 | 1,574.0000 | 58,544,570 | 58.72% | 0.00% |
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 12200 | $0.00 | 12,200.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 22, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 42600 | $0.00 | 42,600.0000 | 58,544,570 | 9999.99% | 0.07% |
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2553 | $36.82 | 2,172.0000 | 58,544,570 | 54.03% | 0.00% |
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 4725 | $0.00 | 4,725.0000 | 58,544,570 | 9999.99% | 0.01% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 3813 | $0.00 | 3,813.0000 | 58,544,570 | 9999.99% | 0.01% |
| Jan. 25, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 4725 | $0.00 | 14,175.0000 | 58,544,570 | 25.00% | 0.01% |
| Jan. 24, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3813 | $0.00 | 7,625.0000 | 58,544,570 | 33.34% | 0.01% |
| Jan. 15, 2026 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 20961 | $35.92 | 0.0000 | 58,544,570 | 100.00% | 0.04% |
| Dec. 5, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 20000 | $29.03 | 20,000.0000 | 58,717,910 | 9999.99% | 0.03% |
| Dec. 5, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 20000 | $39.54 | 0.0000 | 58,717,910 | 100.00% | 0.03% |
| Dec. 5, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Stock Option | 20000 | $0.00 | 185,000.0000 | 58,717,910 | 9.76% | 0.03% |
| Nov. 21, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 3427 | $35.00 | 0.0000 | 58,717,910 | 100.00% | 0.01% |
| Sept. 30, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 45000 | $0.00 | 45,000.0000 | 58,427,134 | 50.00% | 0.08% |
| Sept. 30, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 45000 | $0.00 | 45,000.0000 | 58,427,134 | 9999.99% | 0.08% |
| Sept. 30, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 24039 | $27.56 | 20,961.0000 | 58,427,134 | 53.42% | 0.04% |
| Aug. 15, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 21573 | $36.50 | 0.0000 | 58,427,134 | 100.00% | 0.04% |
| May 28, 2025 | Passage BIO, Inc. | $PASG | Kapadia Sandip | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| April 1, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 740 | $33.12 | 0.0000 | 58,524,566 | 100.00% | 0.00% |
| April 1, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 6247 | $32.48 | 740.0000 | 58,524,566 | 89.41% | 0.01% |
| March 29, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 57,869,915 | 50.00% | 0.03% |
| March 29, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 15000 | $0.00 | 15,000.0000 | 57,869,915 | 9999.99% | 0.03% |
| March 29, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 8014 | $33.19 | 6,986.0000 | 57,869,915 | 53.43% | 0.01% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2037 | $38.01 | 1,775.0000 | 57,869,915 | 53.44% | 0.00% |
| Jan. 25, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 66250 | $0.00 | 66,250.0000 | 57,869,915 | 9999.99% | 0.11% |
| Jan. 25, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 18900 | $0.00 | 18,900.0000 | 57,869,915 | 9999.99% | 0.03% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 3812 | $0.00 | 3,812.0000 | 57,869,915 | 9999.99% | 0.01% |
| Jan. 27, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 1775 | $38.05 | 0.0000 | 57,869,915 | 100.00% | 0.00% |
| Jan. 24, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3812 | $0.00 | 11,438.0000 | 57,869,915 | 25.00% | 0.01% |
| Jan. 21, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Stock Option | 25000 | $0.00 | 205,000.0000 | 57,869,915 | 10.87% | 0.04% |
| Jan. 21, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 25000 | $40.18 | 0.0000 | 57,869,915 | 100.00% | 0.04% |
| Jan. 21, 2025 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 25000 | $29.03 | 25,000.0000 | 57,869,915 | 9999.99% | 0.04% |
| Sept. 30, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 60000 | $0.00 | 60,000.0000 | 57,541,696 | 9999.99% | 0.10% |
| Sept. 30, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 60000 | $0.00 | 90,000.0000 | 57,541,696 | 40.00% | 0.10% |
| Sept. 30, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 32052 | $40.00 | 27,948.0000 | 57,541,696 | 53.42% | 0.06% |
| May 21, 2024 | Passage BIO, Inc. | $PASG | Kapadia Sandip | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| March 29, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 15000 | $0.00 | 15,000.0000 | 60,372,397 | 9999.99% | 0.02% |
| March 29, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 8013 | $33.58 | 6,987.0000 | 60,372,397 | 53.42% | 0.01% |
| March 29, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 60,372,397 | 50.00% | 0.02% |
| Jan. 24, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 15250 | $0.00 | 15,250.0000 | 60,372,397 | 9999.99% | 0.03% |
| Jan. 24, 2024 | Harmony Biosciences Holdings, Inc. | $HRMY | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 74250 | $0.00 | 74,250.0000 | 60,372,397 | 9999.99% | 0.12% |
| May 25, 2023 | Passage BIO, Inc. | $PASG | Kapadia Sandip | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |